Insider Transactions in Q2 2025 at Summit Therapeutics Inc. (SMMT)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2025
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
74,545
+0.01%
|
$149,090
$2.64 P/Share
|
|
May 30
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
74,545
+0.01%
|
$149,090
$2.64 P/Share
|
|
Apr 08
2025
|
Maky Zanganeh Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
3,985,055
+0.71%
|
$3,985,055
$1.58 P/Share
|
|
Apr 08
2025
|
Robert W Duggan Co-Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,985,055
+0.71%
|
$3,985,055
$1.58 P/Share
|